Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2022
Sep. 30, 2021
Current Assets    
Cash and cash equivalents $ 284.4 $ 446.1
Trade receivables, net 304.8 323.5
Receivables from long-term manufacturing contracts, net 197.0 121.9
Inventories, net 506.1 411.6
Prepaid expenses and other current assets 111.9 75.2
Current assets held for sale 0.0 56.2
Total current assets 1,404.2 1,434.5
Property, plant, and equipment, net 280.9 295.1
Operating lease right-of-use assets, net 128.3 138.1
Intangible assets, net 849.3 913.9
Goodwill 1,132.5 1,168.6
Other long-term assets 98.5 64.7
Total Assets 3,893.7 4,014.9
Current Liabilities    
Trade accounts payable 438.7 361.3
Liabilities from long-term manufacturing contracts and advances 253.1 296.6
Current portion of long-term debt 0.0 0.0
Accrued compensation 105.4 123.5
Current liabilities held for sale 0.0 18.9
Other current liabilities 257.5 234.8
Total current liabilities 1,054.7 1,035.1
Long-term debt 1,214.6 1,212.9
Accrued pension and postretirement healthcare 134.6 151.6
Operating lease liabilities 96.7 105.6
Deferred income taxes 182.2 206.7
Other long-term liabilities 60.6 70.8
Total Liabilities 2,743.4 2,782.7
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 75.8 shares issued, 69.7 and 72.7 shares outstanding) 0.0 0.0
Additional paid-in capital 719.5 725.4
Retained earnings 770.5 666.2
Treasury stock (6.1 and 3.1 shares, at cost) (261.8) (135.7)
Accumulated other comprehensive loss (101.2) (46.3)
Hillenbrand Shareholders’ Equity 1,127.0 1,209.6
Noncontrolling interests 23.3 22.6
Total Shareholders’ Equity 1,150.3 1,232.2
Total Liabilities and Shareholders’ Equity $ 3,893.7 $ 4,014.9